Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process vs no Use
CALI
National, Multicentre, Prospective, Interventional Study of the Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process Versus no Use of Normalization Process
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
BrainTale has developed a standardization approach based on averaging measurements in predefined brain regions of interest and use of reference data acquired from healthy volunteers under conditions (MRI machine, acquisition protocol) identical to those used for the examination of the patient. The present study is intended to support the normalization step on healthy volunteers in clinical centres that will be equipped with the BrainTale medical device software dedicated to clinical routine practice and to assess, through a multicentre study, the impact of this normalization step on the variability of the MRI diffusion parameters. The data collected will support characterization and modelisation of the variability to explore further biais corrections methods. The study will be conducted by neuroradiologists of the neuroradiology departments of five clinical centres in France.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2022
CompletedFirst Posted
Study publicly available on registry
July 7, 2022
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedAugust 1, 2023
July 1, 2023
6 months
June 15, 2022
July 31, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Coefficients of Variation (%CV) of FA measurement
Percentage Coefficients of Variation (%CV) of FA measurements obtained from QC-passed DTI sequences before and after application of the normalization process.
Day 1
Secondary Outcomes (3)
Coefficients of Variation (%CV) of MD measurement
Day 1
Coefficients of Variation (%CV) of AD measurement
Day 1
Coefficients of Variation (%CV) of RD measurement
Day 1
Other Outcomes (3)
Intraclass Correlation Coefficient (ICC)
Day 1
percentage Coefficient of Variation (%CV) of the Neurite Orientation Dispersion and Density Imaging (NODDI) multishell diffusion scalar parameters.
Day 1
percentage Coefficient of Variation (%CV) of the resting-state functional MRI (fMRI) parameters.
Day 1
Study Arms (1)
MRI imaging of 10 healthy volunteers
OTHER10 healthy volunteers will proceed at an brain MRI imaging
Interventions
All procedures will be performed during a single visit. Subjects will be invited to lie on the scanning bed that will be moved head first into the scanner such as the head lie under the scanner magnets. Hearing protection will be provided to each subject to muffle the noise produced by the MRI scanner. Subjects will also be provided with pillows and blankets to keep them comfortable. They will also be given a call button that they can push to stop the procedure at any time. MRI acquisition will be performed on 1.5T or 3.0T MRI scanners depending on centre's equipment. Acquisition protocol will include the following sequences with the best parameters chosen by local radiologist and technical BrainTale team.
Eligibility Criteria
You may qualify if:
- Male or female aged 18 up to 80 years old
- Covered by a healthcare insurance
- Agreeing to be informed about any incidental finding discovered on brain MRI
- Written informed consent form signed
You may not qualify if:
- History of brain pathology, cognitive or psychiatric disorder
- Any contraindication \* for undergoing brain MRI
- Subject refusing to participate or having expressed refusal to data collection/processing or unable to give his/her agreement to participate
- Vulnerable subject (i.e. pregnant or breast-feeding woman, child, subject under curatorship or deprived of liberty)
- contraindications to MRI include: pacemaker, neural stimulator, intraocular or intracerebral device, cochlear implant, MR-incompatible prosthetic heart valves, any implant with metallic, ferromagnetic or electrically conductive parts, any metal in the body which cannot be removed, claustrophobia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Braintalelead
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
PERLBARG Vincent
Braintale
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2022
First Posted
July 7, 2022
Study Start
September 1, 2023
Primary Completion
March 1, 2024
Study Completion
May 1, 2024
Last Updated
August 1, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share